Lisata Therapeutics(LSTA) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update Cash runway extending into the fourth quarter of 2026 with no debt, funding current clinical programs through to their next data milestone Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE, NJ (August 7, 2025) – Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of adv ...